object < objective < objectives

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 49.
[0-20] [0 - 20][0 - 49][20-40]

Ident.	Authors (with country if any)	Title
000027 (2020)	Cécile Dumaine [France] ; Sara Bekkar [France] ; Alexandre Belot [France] ; Natalia Cabrera [France] ; Salma Malik [France] ; Annette Von Scheven [Suisse] ; Aurelia Carbasse [France] ; Andreas Woerner [Suisse] ; Carine Wouters [Belgique] ; Kenza Bouayed ; Pascal Pillet [France] ; Silke Schroeder [Suisse] ; Michael Hofer [Suisse] ; Véronique Hentgen [France]	Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte.
000059 (2019)	Jean Darloy [France] ; Nicolas Segaud [France] ; Jean-Hugues Salmon [France] ; Jean-Paul Eschard [France] ; Vincent Goëb [France] ; Xavier Deprez [France] ; Marie-Hélène Guyot [France] ; Eric Houvenagel [France] ; Nicolas Lecuyer [France] ; Laurent Marguerie [France] ; Samuel Gally [France] ; David Pau [France] ; Isabelle Idier [France] ; Guy Baudens [France] ; René-Marc Flipo [France]	Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
000072 (2019)	Olivier Vittecoq [France] ; Sandra Desouches [France] ; Marie Kozyreff [France] ; Julia Nicolau [France] ; Sophie Pouplin [France] ; Pascal Rottenberg [France] ; Nicolas Sens [France] ; Thierry Lequerre [France] ; Gilles Avenel [France]	Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study
000075 (2019)	Cassandra Calabrese [États-Unis] ; Laura C. Cappelli [États-Unis] ; Marie Kostine [France] ; Elizabeth Kirchner [États-Unis] ; Tawnie Braaten [États-Unis] ; Leonard Calabrese [États-Unis]	Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
000089 (2019)	Ana F. Águeda [Portugal] ; Sara Monti [Italie] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne]	Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
000090 (2019)	Jeffrey R. Curtis [États-Unis] ; Xavier Mariette [France] ; Cécile Gaujoux-Viala [France] ; Andrew Blauvelt [États-Unis] ; Tore K. Kvien [Norvège] ; William J. Sandborn [États-Unis] ; Kevin Winthrop [États-Unis] ; Marc De Longueville [Belgique] ; Ivo Huybrechts [Belgique] ; Vivian P. Bykerk [États-Unis]	Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
000094 (2019)	Abrar-Ahmad Zulfiqar [France] ; Rizwan Niazi [France] ; Jean-Loup Pennaforte [France] ; Emmanuel Andres [France]	Late-onset rheumatoid arthritis: clinical, biological, and therapeutic features About a retrospective study.
000096 (2019)	Mélanie Rinaudo-Gaujous ; Vincent Blasco-Baque ; Pierre Miossec ; Philippe Gaudin ; Pierre Farge ; Xavier Roblin ; Thierry Thomas [France] ; Stephane Paul ; Hubert Marotte [France]	Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis Patients
000098 (2019)	Yann Nguyen [France] ; Carine Salliot [France] ; Gaëlle Gusto [France] ; Elise Descamps [France] ; Xavier Mariette [France] ; Marie-Christine Boutron-Ruault [France] ; Raphaèle Seror [France]	Improving accuracy of self-reported diagnoses of rheumatoid arthritis in the French prospective E3N-EPIC cohort: a validation study
000099 (2019)	Emmanuelle Rochette [France] ; Pierre Bourdier [France] ; Bruno Pereira [France] ; Stéphane Echaubard [France] ; Corinne Borderon [France] ; Nicolas Caron [France] ; Aurélie Chausset [France] ; Daniel Courteix [France] ; Solenne Fel [France] ; Justyna Kanold [France] ; Justine Paysal [France] ; Sébastien Ratel [France] ; Nadège Rouel [France] ; Catherine Sarret [France] ; Daniel Terral [France] ; Alexandra Usclade [France] ; Etienne Merlin [France] ; Pascale Duché [France]	Impaired Muscular Fat Metabolism in Juvenile Idiopathic Arthritis in Inactive Disease
000103 (2019)	Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France]	Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses
000116 (2019)	Guillaume Morelle [France] ; Julie Gueudry [France] ; Florence Uettwiller [France] ; Carine Wouters [France] ; Brigitte Bader-Meunier [France] ; Mathieu P. Robert [France] ; Dominique Monnet [France] ; Bahram Bodaghi [France] ; Martine Grall-Lerosey [France] ; Pierre Quartier [France]	Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort
000118 (2019)	Benjamin Castagné [France] ; Marie Viprey [France] ; Julie Martin [France] ; Anne-Marie Schott [France] ; Michel Cucherat [France] ; Martin Soubrier [France]	Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
000120 (2019)	Iain B. Mcinnes [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Maria-Antonietta D'Agostino [France] ; Manuela Le Bars [France] ; Subhashis Banerjee [États-Unis] ; Harris A. Ahmad [États-Unis] ; Yedid Elbez [France] ; Philip J. Mease [États-Unis]	Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial
000211 (2018)	Valérie Devauchelle-Pensec [France] ; Lea Saraux [France] ; Jean Marie Berthelot [France] ; Michel De Bandt [France] ; Divi Cornec [France] ; Dewi Guellec [France] ; Thierry Marhadour [France] ; Sandrine Jousse-Joulin [France] ; Maelenn Gouillou [France] ; Alain Saraux [France]	Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable.
000217 (2018)	Amandine Le Bourgeois [France]
000243 (2017)	Vibeke Strand [États-Unis] ; Matthew Reaney [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Clare W J. Proudfoot [Royaume-Uni] ; Sophie Guillonneau [France] ; Deborah Bauer [États-Unis] ; Erin Mangan [États-Unis] ; Neil M H. Graham [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Yong Lin [États-Unis] ; César Pacheco-Tena [Mexique] ; Roy Fleischmann [États-Unis]	Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors
000247 (2017)	Silvio Danese [Italie] ; Séverine Vermeire [Belgique] ; Paul Hellstern [États-Unis] ; Remo Panaccione [Canada] ; Gerhard Rogler [Suisse] ; Gerald Fraser [Israël] ; Anna Kohn [Italie] ; Pierre Desreumaux [France] ; Rupert W. Leong [Australie] ; Gail M. Comer [États-Unis] ; Fabio Cataldi [États-Unis] ; Anindita Banerjee [États-Unis] ; Mary K. Maguire [États-Unis] ; Cheryl Li [États-Unis] ; Natalie Rath [États-Unis] ; Jean Beebe [États-Unis] ; Stefan Schreiber [Allemagne]	Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)
000252 (2017)	C. Derambure [France] ; G. Dzangue-Tchoupou [France] ; C. Berard [France] ; N. Vergne [France] ; M. Hiron [France] ; M. A. D Gostino [France] ; P. Musette [France] ; O. Vittecoq [France] ; T. Lequerré [France]	Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis
000255 (2017)	Claire Immediato Daien [France] ; Charlotte Hua [France] ; Bernard Combe [France] ; Robert Landewe [Pays-Bas]	Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis
000262 (2017)	Nathalie Balandraud [France] ; Gaetan Texier [France] ; Emmanuel Massy [France] ; Olivier Muis-Pistor [France] ; Marielle Martin [France] ; Isabelle Auger [France] ; Marie-Caroline Guzian [France] ; Sandrine Guis [France] ; Thao Pham [France] ; Jean Roudier [France]	Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i -k "objective" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i  \
                -Sk "objective" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    objective
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021